ACEL Accel Entertainment, Inc.
Accel Entertainment, Inc., together with its subsidiaries, operates as a distributed gaming operator in the United States. It engages in the installation, maintenance, and operation of gaming terminals; redemption devices that disburse winnings and contain automated teller machine (ATM) functionality; and other amusement devices in authorized non-casino locations, such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The company also designs and manufactures gaming terminals and related equipment, as well as offers turnkey and full-service gaming solutions to bars, restaurants, convenience stores, truck stops, and fraternal and veteran establishments. In addition, it operates stand-alone ATMs in gaming and non-gaming locations, as well as amusement devices, including jukeboxes, dartboards, pool tables, and other entertainment related equipment; and develops brick-and-mortar casinos that serve local gaming markets and horse racing venues. Accel Entertainment, Inc. is headquartered in Burr Ridge, Illinois.…
Industry Peers
GamblingKey Statistics
About Accel Entertainment (NYSE: ACEL)
›
Accel Entertainment (NYSE: ACEL) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Gambling industry, part of the Consumer Cyclical sector, and reports about 1,600 employees.
The shares were at 13.21 USD on 19 November 2026, up 30.3% over 52 weeks. Its 52-week range is 9.550 USD to 14.08 USD: the price is 6.2% below the high and 38.3% above the low.
At a market capitalisation of 1.06B USD, it trades at 17.4 times trailing earnings and 12.1 times forward earnings. The median trailing P/E of its 17 largest Gambling peers is 22.1, a discount of 21% for ACEL.
Accel Entertainment reports return on equity of 19.1%, an operating margin of 8.8% and revenue up 10.3% year over year.
Its debt exceeds its cash by 271.74M USD, a debt-to-equity ratio of 2.25. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 7 analysts cover the stock, with an average rating of Buy; their mean price target of 15.71 USD is 19.0% above the current price. The next earnings report is expected on 2 March 2027.